Contents

CNS & Neurological Disorders - Drug Targets , Volume 7 - Number 5

Editorial [Hot Topic: Drug Addiction and Brain Targets: From Preclinical Research to Pharmacotherapy (Guest Editor: Shafiqur Rahman)]

, 7(5): 391 - 392

Shafiqur Rahman


DOI: 10.2174/187152708786927840




Role of the Dopamine Transporter in the Action of Psychostimulants, Nicotine, and Other Drugs of Abuse

, 7(5): 393 - 409

J. Zhu and M. E.A. Reith


DOI: 10.2174/187152708786927877




Selective Antagonism at Dopamine D3 Receptors as a Target for Drug Addiction Pharmacotherapy: A Review of Preclinical Evidence

, 7(5): 410 - 421

Christian Heidbreder


DOI: 10.2174/187152708786927822




Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction

, 7(5): 422 - 441

Shafiqur Rahman, Gretchen Y. Lopez-Hernandez, William A. Corrigall and Roger L. Papke


DOI: 10.2174/187152708786927831




Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

, 7(5): 442 - 453

T. S. Shippenberg, A. LeFevour and V. I. Chefer


DOI: 10.2174/187152708786927813




The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy

, 7(5): 454 - 467

E. A. Engleman, Z. A. Rodd, R. L. Bell and J. M. Murphy


DOI: 10.2174/187152708786927886




The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction

, 7(5): 468 - 481

Maria Scherma, Paola Fadda, Bernard Le Foll, Benoit Forget, Walter Fratta, Steven R. Goldberg and Gianluigi Tanda


DOI: 10.2174/187152708786927859




Glutamate: The New Frontier in Pharmacotherapy for Cocaine Addiction

, 7(5): 482 - 491

Joachim D. Uys and Ryan T. LaLumiere


DOI: 10.2174/187152708786927868




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science